XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 16.06.2025

The following instruments on Boerse Frankfurt do have their last trading day on 16.06.2025
Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 16.06.2025

ISIN Name
GB00BLNNFY18 HARMONY ENERGY INCOME TR.
LU0039632921 UNIRENTACORP INH. A
LU0055734320 UNIRESERVE: EURO A
LU0059863547 UNIRESERVE: USD
LU0192293511 UNIEURORENTA REAL ZINS A
LU0192294089 UNIEURORENTA REAL -NET-A
LU0247467987 UNIRESERVE:EO-CORPORATES
NL0012170237 PLAYA HOTELS+RES. EO -,10
SE0014855292 READLY INTERNATIONAL AB
US23344D1081 DADA NEXUS LTD ADS
US31572Q8087 FIBROGEN INC. DL-,01
US3498531017 FORWARD AIR CORP. DL-,01
US75382E1091 RAPT THERAP. INC.DL-,0001
US81728A1088 SENSEI BIOTHER. DL -,0001

Zeit	Aktuelle Nachrichten
02.10.	XFRA 1FG0: WIEDERAUFNAHME/RESUMPTION	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen
25.09.	FibroGen stock advances as H.C. Wainwright reiterates Buy rating on FG-3246 progress
24.09.	FibroGen initiates phase 2 trial of FG-3246 for prostate cancer
24.09.	FibroGen, Inc.: FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer	FG-3246 Phase 2 dose optimization trial to enroll 75 patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-androgen receptor signaling inhibitor (ASRI) and pre-chemotherapy... ► Artikel lesen
11.09.	FibroGen pays SEC $1.2M over allegations former exec 'reverse engineered' roxadustat data

Zeit

Aktuelle Nachrichten

02.10.

XFRA 1FG0: WIEDERAUFNAHME/RESUMPTION

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen

25.09.

FibroGen stock advances as H.C. Wainwright reiterates Buy rating on FG-3246 progress

24.09.

FibroGen initiates phase 2 trial of FG-3246 for prostate cancer

24.09.

FibroGen, Inc.: FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer

FG-3246 Phase 2 dose optimization trial to enroll 75 patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-androgen receptor signaling inhibitor (ASRI) and pre-chemotherapy...
► Artikel lesen

11.09.

FibroGen pays SEC $1.2M over allegations former exec 'reverse engineered' roxadustat data

Zeit	Aktuelle Nachrichten
21.10.	No deal for Forward Air sends shares lower
20.10.	Forward Air falls on report that auction process has slowed
20.10.	Forward Air-Aktie bricht um 17 % ein: Bieterverfahren stockt wegen unzureichender Gebote
20.10.	Forward Air stock falls 17% as auction process slows amid tepid bids
17.10.	Forward Air stock price target raised to $32 by Stifel on potential sale

Zeit

Aktuelle Nachrichten

21.10.

No deal for Forward Air sends shares lower

20.10.

Forward Air falls on report that auction process has slowed

20.10.

Forward Air-Aktie bricht um 17 % ein: Bieterverfahren stockt wegen unzureichender Gebote

20.10.

Forward Air stock falls 17% as auction process slows amid tepid bids

17.10.

Forward Air stock price target raised to $32 by Stifel on potential sale

Zeit	Aktuelle Nachrichten
18.06.	Stock Exch Notice - Cancellation - Harmony Energy Income Trust PLC
17.06.	Stock Exch Notice - Suspension - Harmony Energy Income Trust plc
17.06.	Harmony Energy Income Trust - Scheme of Arrangement Becomes Effective
16.06.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 16.06.2025	The following instruments on Boerse Frankfurt do have their last trading day on 16.06.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 16.06.2025ISIN NameGB00BLNNFY18 HARMONY... ► Artikel lesen
16.06.	XFRA CAPITAL ADJUSTMENT INFORMATION - 16.06.2025	Das Instrument F62 NO0012697715 ENERGEIA AS NK 60 EQUITY wird ex Kapitalmassnahme gehandelt am 16.06.2025 The instrument F62 NO0012697715 ENERGEIA AS NK 60 EQUITY is traded ex capital adjustment on... ► Artikel lesen

Zeit

Aktuelle Nachrichten

18.06.

Stock Exch Notice - Cancellation - Harmony Energy Income Trust PLC

17.06.

Stock Exch Notice - Suspension - Harmony Energy Income Trust plc

17.06.

Harmony Energy Income Trust - Scheme of Arrangement Becomes Effective

16.06.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 16.06.2025

16.06.

XFRA CAPITAL ADJUSTMENT INFORMATION - 16.06.2025

Das Instrument F62 NO0012697715 ENERGEIA AS NK 60 EQUITY wird ex Kapitalmassnahme gehandelt am 16.06.2025 The instrument F62 NO0012697715 ENERGEIA AS NK 60 EQUITY is traded ex capital adjustment on...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Mo	Guggenheim initiates Rapt Therapeutics stock with Buy rating on food allergy drug potential
Do	RAPT Therapeutics, Inc. - 8-K, Current Report
Mi	RAPT Therapeutics prices equity offering at $30 per share
Mi	RAPT Therapeutics: Aktienplatzierung zu 30 US-Dollar soll 250 Millionen US-Dollar einbringen
Mi	RAPT Therapeutics prices public offering at $30 per share

Zeit

Aktuelle Nachrichten

Guggenheim initiates Rapt Therapeutics stock with Buy rating on food allergy drug potential

RAPT Therapeutics, Inc. - 8-K, Current Report

RAPT Therapeutics prices equity offering at $30 per share

RAPT Therapeutics: Aktienplatzierung zu 30 US-Dollar soll 250 Millionen US-Dollar einbringen

RAPT Therapeutics prices public offering at $30 per share

Zeit	Aktuelle Nachrichten
17.10.	Readly appoints Chloe Rushmere as new Head of Content UK
14.10.	Q3 Operational update: Readly shows continued growth and improves accessibility in the app
05.09.	Readly: Brits say writing standards have declined with the digital era whilst reading opportunities have risen: International Literacy Day (8 September)	LONDON, Sept. 5, 2025 /PRNewswire/ -- Almost half of Brits (44 percent) believe that their writing standards have declined with technology but that their overall literacy and reading has... ► Artikel lesen
28.07.	Body Positivity: Brits Tired of Airbrushing and Two Thirds Demand more 'Normal' Body Representation - Readly Survey Reveals	LONDON, July 28, 2025 /PRNewswire/ -- Weight loss drugs, extreme workouts and protein rich diets are being well documented on social media and shaping body ideals, yet 68 percent of Brits... ► Artikel lesen
11.07.	Q2 Operational update: Readly returns to subscriber growth and has continued 2025 with robust profitability

Zeit

Aktuelle Nachrichten

17.10.

Readly appoints Chloe Rushmere as new Head of Content UK

14.10.

Q3 Operational update: Readly shows continued growth and improves accessibility in the app

05.09.

Readly: Brits say writing standards have declined with the digital era whilst reading opportunities have risen: International Literacy Day (8 September)

LONDON, Sept. 5, 2025 /PRNewswire/ -- Almost half of Brits (44 percent) believe that their writing standards have declined with technology but that their overall literacy and reading has...
► Artikel lesen

28.07.

Body Positivity: Brits Tired of Airbrushing and Two Thirds Demand more 'Normal' Body Representation - Readly Survey Reveals

LONDON, July 28, 2025 /PRNewswire/ -- Weight loss drugs, extreme workouts and protein rich diets are being well documented on social media and shaping body ideals, yet 68 percent of Brits...
► Artikel lesen

11.07.

Q2 Operational update: Readly returns to subscriber growth and has continued 2025 with robust profitability

Zeit	Aktuelle Nachrichten
17.10.	Sensei Biotherapeutics Shares Drop 34% On Phase 1/2 Trial Data Of Solnerstotug
17.10.	Sensei Biotherapeutics stock falls after Phase 1/2 trial results
17.10.	Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025
17.10.	Sensei Biotherapeutics, Inc. - 8-K, Current Report
23.09.	Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025

Zeit

Aktuelle Nachrichten

17.10.

Sensei Biotherapeutics Shares Drop 34% On Phase 1/2 Trial Data Of Solnerstotug

17.10.

Sensei Biotherapeutics stock falls after Phase 1/2 trial results

17.10.

Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025

17.10.

Sensei Biotherapeutics, Inc. - 8-K, Current Report

23.09.

Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025

Unternehmen / Aktien	Kurs	%
FIBROGEN INC	9,100	-0,55 %
FORWARD AIR CORPORATION	17,100	+0,59 %
HARMONY ENERGY INCOME TRUST PLC	1,070	0,00 %
RAPT THERAPEUTICS INC	25,200	-2,33 %
READLY INTERNATIONAL AB	2,410	0,00 %
SENSEI BIOTHERAPEUTICS INC	10,110	0,00 %

Unternehmen / Aktien

Kurs

FIBROGEN INC

9,100

-0,55 %

FORWARD AIR CORPORATION

17,100

+0,59 %

HARMONY ENERGY INCOME TRUST PLC

1,070

0,00 %

RAPT THERAPEUTICS INC